terfenadine (Compound)

Synonyms:terfenadine, 50679-08-8, Seldane, Ternadin, Triludan, Teldane, Allerplus, Teldanex, Aldaban, Terdin, Terfenadina, RMI 9918, RMI-9918, 1-(4-(tert-butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol, 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol, alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, MDL-9918, NSC-665802, NSC-758627, alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, CHEMBL17157, 1-Piperidinebutanol, .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-, MLS000028499, 7BA5G9Y06Q, CHEBI:9453, DTXSID2023642, Cyater, Terfen, 1-(4-tert-butylphenyl)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-ol, alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, NCGC00016064-04, NCGC00016064-06, Terfenadinum, SMR000058260, Terfex, 1-(4-(tert-Butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)-piperidin-1-yl)butan-1-ol, Terfenadinum [INN-Latin], Terfenadina [INN-Spanish], DTXCID503642, 1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol, MDL 9918, alpha-(4-[1,1-Dimethylethyl]phenyl)-4-[hydroxydiphenylmethyl]-1-piperidinebutanol, Seldane (TN), HSDB 6508, SR-01000000104, EINECS 256-710-8, MFCD00079622, BRN 5857899, teraenadine, UNII-7BA5G9Y06Q, Terfenadin, Terfenadine (JAN/USAN/INN), Terfenadine,(S), (-)-Terfenadine, 1-PIPERIDINEBUTANOL, .ALPHA.-(4-(1,1-DIMETHYLETHYL)PHENYL)-4-(HYDROXYDIPHENYLMETHYL)-, Prestwick_460, 1-(4-tert-Butylphenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol, 1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)butanol, CAS-50679-08-8, 1-Piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-, Terfenadine [USAN:USP:INN:BAN:JAN], Opera_ID_334, TERFENADINE [MI], Prestwick0_000138, Prestwick1_000138, Prestwick2_000138, Prestwick3_000138, TERFENADINE [INN], TERFENADINE [JAN], (.+/-.)-Terfenadine, TERFENADINE [HSDB], TERFENADINE [USAN], T 9652, TERFENADINE [VANDF], SCHEMBL5152, TERFENADINE [MART.], Lopac0_001213, Oprea1_343139, BSPBio_000216, TERFENADINE [WHO-DD], MLS001148415, DivK1c_001011, SPBio_002155, BPBio1_000238, GTPL2608, HMS503K03, KBio1_001011, MDL-991, TERFENADINE [EP IMPURITY], NINDS_001011, HMS1568K18, HMS2089I14, HMS2093I11, HMS2095K18, HMS2231N07, HMS3263D08, HMS3373J07, HMS3712K18, Pharmakon1600-01503708, TERFENADINE [EP MONOGRAPH], HY-B1193, Tox21_110295, Tox21_110296, Tox21_501213, AC-928, BDBM50017376, NSC665802, NSC758627, s4353, AKOS015962091, Tox21_110295_1, CCG-205287, CS-4800, DB00342, LP01213, NSC 665802, NSC 758627, SDCCGSBI-0051180.P004, 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol, 1-[4-(1,1-dimethylethyl)phenyl]-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol, IDI1_001011, NCGC00016064-03, NCGC00016064-05, NCGC00016064-08, NCGC00016064-09, NCGC00016064-12, NCGC00016064-19, NCGC00089746-02, NCGC00089746-03, NCGC00089746-04, NCGC00261898-01, ( inverted exclamation markA)-Terfenadine, AC-15791, AS-75636, BT166253, NCI60_022784, SBI-0051180.P003, DB-051821, AB00052367, EU-0101213, FT-0630637, SW196677-3, T3977, BIM-0051180.0001, C07463, D00521, D82079, AB00052367-16, AB00052367_17, AB00052367_18, A828247, EN300-22527913, L000888, Q417909, ( inverted exclamation markA)-Terfenadine;MDL-991, ( inverted exclamation markA)-Terfenadine;MDL-9918, SR-01000000104-2, SR-01000000104-4, SR-01000000104-7, BRD-A06352418-001-03-6, BRD-A06352418-001-15-0, Terfenadine, European Pharmacopoeia (EP) Reference Standard, Terfenadine, United States Pharmacopeia (USP) Reference Standard, .alpha.-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, (+/-)1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol, (RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol, .alpha.-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine butanol, .alpha.-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, 1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol, 1-(4-tert-Butylphenyl)-4-(4-[hydroxy(diphenyl)methyl]-1-piperidinyl)-1-butanol #, 1-(4-tert-butylphenyl)-4-[4-[hydroxy-di(phenyl)methyl]piperidin-1-yl]butan-1-ol, a-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, alpha-[4-(1,1-Dmethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol, 1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol(Terfenadine)
Pubchem:PUBCHEM:5405
Id:8d1c3b7e-79bd-5997-a2bf-a4955b5beac5
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View terfenadine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for terfenadine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with terfenadine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.